Friends of Cancer Research initiated a new research partnership, Digital and Computational Pathology Tool Harmonization, or Digital PATH, Project. The project will identify factors that may contribute to variability in biomarker assessment across computational pathology platforms, propose areas for alignment in the field, and provide insights for shaping regulatory processes.
More than a decade ago, Glenn Begley and Lee Ellis published a paper with astounding findings: of 53 “landmark” studies, only six, or 11%, were reproducible, even with the same reagents and the same protocols—and even, sometimes, in the same laboratory—as the original study.
FDA has directed the sponsors of CAR T-cell therapies to place boxed warnings on their products to indicate that the agents may cause secondary T-cell malignancies.
Sheldon L. Holder knew he wanted to pursue a career in medicine in the second grade, thanks to a career day at his school on the island of Bermuda.
Seventeen scientists have received NCI’s 2023 Outstanding Investigator Awards, with up to $600,000 in direct costs per year over six years.
C. Norman “Norm” Coleman has received the 2023 D.A. Henderson Lifetime Achievement Award, bestowed by the Administration for Strategic Preparedness and Response in the U.S. Department of Health and Human Services.
David Pfister, chief of the Head and Neck Service at Memorial Sloan Kettering, has decided to step down from this role after more than 20 years of leadership. He will remain in the position until a successor has been selected.
Pamela Kunz was named editor-in-chief of JCO Oncology Advances, a new open-access journal published by The American Society of Clinical Oncology.
Michael T. Lotze was named editor-in-chief of Society for Immunotherapy of Cancer’s official journal, Journal for ImmunoTherapy of Cancer.
MD Anderson Cancer Center has signed an agreement with the International Atomic Energy Agency to become an IAEA Collaborating Centre.
